Skip to content
WeighLab

MedLeanRx vs Layla

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

MedLeanRx

Provider comparison

Texas residents who want a named supervising physician and a brand-name option alongside compounded GLP-1s.

Semaglutide / month
$149/moCompounded oral
Tirzepatide / month
$269/moCompounded
Index 58/100 · Grade CChecked August 2026

Layla

Provider comparison

Shoppers who want brand-name Ozempic, Wegovy, Zepbound or Mounjaro with check-ins included and don't need a lower-cost compounded option.

Semaglutide / month
$1,399/moBrand Ozempic, promotional rate
Tirzepatide / month
$1,399/moBrand Mounjaro, promotional rate
Index 57/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

MedLeanRx has the higher Cost-Efficiency Index: 58/100 versus 57/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

MedLeanRx
1 state
Layla
Coverage not published

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

MedLeanRx

Layla

Semaglutide / month
MedLeanRx: $149/moCompounded oral
Layla: $1,399/moBrand Ozempic, promotional rate
Tirzepatide / month
MedLeanRx: $269/moCompounded
Layla: $1,399/moBrand Mounjaro, promotional rate
Semaglutide / year (modeled)
MedLeanRx: $1,788
Layla: $16,788
Tirzepatide / year (modeled)
MedLeanRx: $3,228
Layla: $16,788
State availability
MedLeanRx: 1 state
Layla: Coverage not published
Oral / sublingual option listed
MedLeanRx: Yes
Layla: Not listed
Brand-name access listed
MedLeanRx: Yes
Layla: Yes
Provider facts checked
MedLeanRx: August 2026
Layla: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

MedLeanRx

Texas residents who want a named supervising physician and a brand-name option alongside compounded GLP-1s.

Reasons to consider it

  • Named supervising physician (Dr. Johnson Uzor, MD) publicly disclosed with a dedicated bio page
  • Both compounded semaglutide (injectable and oral tablet) and a brand Wegovy/Zepbound/Foundayo pathway offered on one platform
  • Flat pricing with no dose-tier escalation disclosed

What to weigh up

  • Texas only — not available in any other state
  • Compounding pharmacy is never named anywhere on the site
  • The Terms & Conditions state 'All sales are final' — no refund policy

Layla

Shoppers who want brand-name Ozempic, Wegovy, Zepbound or Mounjaro with check-ins included and don't need a lower-cost compounded option.

Reasons to consider it

  • All-inclusive pricing bundles health check-ins, telehealth visits, prescription and unlimited doctor messaging into one price
  • Names its Medical Director (Dr. Ruth Cohen) on its site
  • LegitScript-certified badge displayed; fast 2-3 day shipping claimed

What to weigh up

  • Brand-only and expensive: the real floor is $1,399/mo (Ozempic/Mounjaro), not the $1,299 the homepage FAQ separately claims — the two figures don't reconcile
  • The lowest Zepbound figure shown ($1,599) is a one-time new-customer discount off a $1,699 standing price, not an ongoing rate
  • No compounded or lower-cost option on the current site, and states served are not published

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

MedLeanRxLayla
Normalized Cost/Month
MedLeanRx:
31/100
Layla:
41/100
Price Transparency
MedLeanRx:
78/100
Layla:
78/100
Nationwide Access
MedLeanRx:
42/100
Layla:
24/100
Formulation Options
MedLeanRx:
90/100
Layla:
79/100
Clinical Oversight
MedLeanRx:
77/100
Layla:
81/100
Contract Flexibility
MedLeanRx:
47/100
Layla:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.